We are at a tipping point. The convergence of genomics and digital data is enabling the development of superior therapeutics, diagnostics, and delivery models. Breakthrough science is transforming medicine into a value-based healthcare system, leading to lower costs and better patient outcomes.
Biomatics helps create the next generation of companies that will lead this transformation.
Biomatics is transformational for portfolio companies with which they work. Their counsel to me has been invaluable: they are always there to help when called upon, will roll up their sleeves and be a part of the team when needed, and appropriately challenges me think about the long term and massive impact we can have on healthcare. I could not do this without them.
Biomatics’ savvy, nimble team has both exceptional vision and execution from gene editing to DNA synthesis. Their passion for groundbreaking technologies combined with their business acumen allows entrepreneurs to experience a very different kind of support as they brave new territory. Most importantly, Biomatics becomes is a true partner, advising and creating a vital network of experts to truly create exceptional value.
Working with our Biomatics colleagues is an ongoing pleasure. They provide keen scientific and business insights and are always in my corner. They are willing to help in any way to ensure the company’s greatest chances for success. They are truly “value add”.
The Biomatics team has been truly superb in helping us to launch Alairion. They have advised us in business model refinement, detailed R&D plans, development of investor presentations, and introductions to the highest quality investors. Our experience with them as individuals has also been simply outstanding, and their team really cares about creating long-term successful companies with winning strategies.